Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 1, 1996, Pages 127-132

  Chanal, C ^a   Sirot, D ^a   Romaszko, J P ^a   Bret, L ^a   Sirot, J ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; ENZYME INHIBITOR;

ARTICLE; BIOSYNTHESIS; DRUG ANTAGONISM; ENTEROBACTERIACEAE; ENZYMOLOGY; ISOLATION AND PURIFICATION; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; AZTREONAM; BETA-LACTAMASES; CEFOTAXIME; CEFTAZIDIME; ENTEROBACTERIACEAE; ENZYME INHIBITORS; HOSPITALS, TEACHING;

EID: 0030180076     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.1.127     Document Type: Review

References (11)

1. Antibiogram Commitee of the French Society for Microbiology. (1994). 1994 Statement. Pathologie Biologie 42, 1-8.
2. Chanal, C. M., Sirot, D., Labia, R., Petit, A., Morand, A., Sirot, J. et al. (1988). Comparative study of a novel plasmid-mediated β-lactamase. CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 32, 1660-5.
3. Chanal, C. M., Sirot, D. L., Petit, A., Labia, R., Morand, A., Sirot, J. et al. (1989). Multiplicity of TEM-derived β-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrobial Agents and Chemotherapy 33, 1915-20.
4. de Champs, C., Sirot, D., Chanal, C., Poupart, M. C., Dumas, M. P. & Sirot, J. (1991). Concomitant dissemination of three extended-spectrum β-lactamases among different Enterobacteriaceae isolated in a French hospital. Journal of Antimicrobial Chemotherapy 27, 441-57.
5. Jarlier, V., Nicolas, M. H., Fournier, G. & Philippon, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 10, 867-878.
6. Petit, A., Gerbaud, G., Sirot, D., Courvalin, P. & Sirot, J. (1990). Molecular epidemiology of TEM-3 (CTX-1) β-lactamase. Antimicrobial Agents and Chemotherapy 34, 219-24.
7. Petit, A., Sirot, D., Chanal, C. M., Sirot, J. L., Labia, R., Gerbaud, G. et al. (1988). Novel plasmid-mediated β-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 32, 626-30.
8. Poupart, M. C., Chanal, C., Sirot, D., Labia, R. & Sirot, J. (1991). Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrobial Agents and Chemotherapy 35, 1498-500.
9. Sirot, D., Chanal, C., Labia, R., Meyran, M., Sirot, J. & Cluzel, R. (1989). Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy 24, 509-21.
10. Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A. et al. (1987). Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. Journal of Antimicrobial Chemotherapy 20, 323-34.
11. Sirot, J., Chanal, C., Petit, A., Sirot, D., Labia, R. & Gerbaud, G. (1988). Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Reviews of Infectious Diseases 10, 850-9.